Other Information
−Removed: During the three months ended June 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
+Added: During the three months ended September 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
Action Date Trading Arrangement Total Shares to be Purchased or Sold Duration/Expiration Date
Rule 10b5-1* Non-Rule 10b5-1**
−Removed: Troendle , Chief Executive Officer and Chairman of the Board
−Removed: Adopt April 25, 2024 [1]
−Removed: X Up to 190,000 shares to be sold
−Removed: Good until cancelled
−Removed: Troendle , Chief Executive Officer and Chairman of the Board
−Removed: Modify May 22, 2024 [2]
−Removed: X Up to 190,000 shares to be sold
−Removed: Good until cancelled
−Removed: Troendle , Chief Executive Officer and Chairman of the Board
−Removed: Terminate May 30, 2024 [3]
−Removed: X Up to 190,000 shares to be sold
−Removed: Good until cancelled
−Removed: Burwig , Executive Vice President, Operations
−Removed: Adopt June 5, 2024 [4]
+Added: Kraft , Director
+Added: Adopt August 22, 2024 [1]
X Up to 8,127 shares to be sold
−Removed: The earlier of until cancelled or 180 days from the placement of the limit order
+Added: August 28, 2024
* Intended to satisfy the affirmative defense of Rule 10b5-1(c).
** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
−Removed: [1] On April 25, 2024 , August J.
−Removed: Troendle placed a limit order to sell up to 190,000 shares that were previously acquired through various stock option exercises.
−Removed: Between April 25, 2024 and May 21, 2024, Mr.
−Removed: Troendle sold 142,250 shares pursuant to the limit order.
−Removed: [2] On May 22, 2024 , August J.
−Removed: Troendle changed the price limit for sales under the limit order originally adopted on April 25, 2024.
−Removed: [3] On May 30, 2024 , August J.
−Removed: Troendle terminated the limit order originally adopted on April 25, 2024.
−Removed: [4] On June 5, 2024 , Ms.
−Removed: Burwig placed a limit order to sell up to 7,681 shares that were acquired upon the vesting of restricted shares.
+Added: [1] On August 22, 2024 , Robert O.
+Added: Kraft placed a limit order to sell up to 8,127 shares issued to him pursuant to his contemporaneous exercise of stock options .
The exhibits in the accompanying Exhibit Index preceding the signature page are filed or furnished as a part of this report and are incorporated herein by reference.
3 unchanged sentences
Exhibit Filing
−Removed: 3.1 Restated Certificate of Incorporation
−Removed: 8-K 001-37856 3.1 5/21/2024
−Removed: 3.2 Second Amended and Restated Bylaws
−Removed: 8-K 001-37856 3.2 5/21/2024
+Added: #10.1 Form of Medpace Holdings, Inc.
+Added: 2016 Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement
+Added: #10.2 Form of Medpace Holdings, Inc.
+Added: 2016 Incentive Award Plan Restricted Stock Unit Award Grant Notice
31.1 Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer
11 unchanged sentences
** Furnished herewith.
+Added: # Indicates management contract or compensatory plan.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
2 unchanged sentences
(Principal Financial Officer)
−Removed: July 23, 2024
+Added: October 22, 2024
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.